Guggenheim has initiated Metsera at buy saying that the biotech's pipeline of injectable and oral nutrient stimulated hormone ...

Guggenheim has initiated coverage of Metsera (NASDAQ:MTSR) with a buy rating, citing the company's obesity drug candidates.

Guggenheim reaffirmed their buy rating on shares of Veracyte (NASDAQ:VCYT – Free Report) in a report published on Tuesday morning,Benzinga reports. The firm currently has a $45.00 price objective on ...

The performance artist Marina Abramovic celebrated the announcement of a new cultural center in a private home designed by ...

The trial of three men accused in the theft or sale of an 18-carat gold toilet that was a pricey piece of satirical art is ...

Guggenheim reaffirmed their buy rating on shares of CyberArk Software (NASDAQ:CYBR – Free Report) in a research note issued ...

As previously reported, Guggenheim analyst Michael Schmidt initiated coverage of Compass Therapeutics (CMPX) with a Buy rating and $12 price ...

As previously reported, Guggenheim analyst Gregory Francfort upgraded Wingstop (WING) to Buy from Neutral with a $280 price target Despite ...

Guggenheim analyst sees significant upside in Metsera stock to $56. MTSR is working on both injectable and oral weight-loss ...

The artist is known for creating futuristic, interactive environments that reflect on contemporary geopolitical and ...

In Miami Beach, Fla., a waterfront estate asking $88 million has elements inspired by Manhattan’s Guggenheim Museum.

LG and the Guggenheim New York proudly announce Ayoung Kim as the 2025 LG Guggenheim Award recipient. Kim is the third artist to be recognized as part of the LG Guggenheim Art and Technology ...